Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1990-04-30
1991-07-09
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424468, A61K 934
Patent
active
050304569
ABSTRACT:
An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4063064 (1977-12-01), Saunder et al.
patent: 4088864 (1978-05-01), Theeuwes et al.
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4723957 (1988-02-01), Magruder et al.
patent: 4764378 (1988-08-01), Keith et al.
patent: 4867969 (1989-09-01), Magruder et al.
patent: 4873086 (1989-10-01), Good et al.
Greenberg, MD, Barry et all., The Amer. Jol. of Cardiology, vol 59, Jan. 30, 1987, pp. 70B-74B, "Hemodynamic Effects of PN 200-100 (Isradipine) in Congestive Heart Failure."
Ayer Atul D.
Kuczynski Anthony L.
Swanson David R.
ALZA Corporation
Horne Leon R.
Mandell Edward L.
Page Thurman K.
Sabatine Paul L.
LandOfFree
Dosage form for treating cardiovascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage form for treating cardiovascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form for treating cardiovascular diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-617125